39 results
DEFM14A
HARP
Harpoon Therapeutics Inc
8 Feb 24
Proxy related to merger
7:00am
Lincoln Avenue, Rahway, NJ 07065, telephone number (908) 423-1000. Merck Parent is a global health care company that delivers innovative health solutions … , New Jersey 07065, telephone number (908) 740-4000. Merck Parent is a global health care company that delivers innovative health solutions through
PREM14A
HARP
Harpoon Therapeutics Inc
29 Jan 24
Preliminary proxy related to merger
4:52pm
Avenue, Rahway, NJ 07065, telephone number (908) 423-1000. Merck Parent is a global health care company that delivers innovative health solutions through … that delivers innovative health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products
DFAN14A
HARP
Harpoon Therapeutics Inc
10 Jan 24
Additional proxy materials by non-management
5:05pm
and sovereign risk; dependence on the effectiveness of Merck’s patents and other protections for innovative products; and the exposure to litigation, including … protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
Merck undertakes
DFAN14A
HARP
Harpoon Therapeutics Inc
8 Jan 24
Additional proxy materials by non-management
5:15pm
look forward to further evaluating HPN328 in innovative combinations with other pipeline candidates.”
Harpoon has developed a portfolio of novel T-cell … platform to develop an innovative suite of candidates, and we are pleased that Merck has recognized the significant potential of our pipeline. I want
DEFA14A
HARP
Harpoon Therapeutics Inc
8 Jan 24
Additional proxy soliciting materials
8:04am
to further evaluating HPN328 in innovative combinations with other pipeline candidates.”
Harpoon has developed a portfolio of novel T-cell engagers … an innovative suite of candidates, and we are pleased that Merck has recognized the significant potential of our pipeline. I want to personally thank all
8-K
EX-99.2
mu2a9x5vkp0mrksyv7u
8 Jan 24
Entry into a Material Definitive Agreement
8:01am
8-K
EX-99.2
esbl 8prv2e
7 Jan 21
Harpoon Therapeutics Announces Pricing of Public Offering of Common Stock
4:20pm
424B5
n3hxy1c6qbq 1fqraqvh
7 Jan 21
Prospectus supplement for primary offering
4:16pm